Clinical and Experimental Dermatology最新文献

筛选
英文 中文
Bony side-effects in acitretin treatment: is monitoring required? 阿维A酸治疗中的骨质副作用:是否需要监测?
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2024-11-22 DOI: 10.1093/ced/llae266
Jenny G Chung, Khawar Hussain
{"title":"Bony side-effects in acitretin treatment: is monitoring required?","authors":"Jenny G Chung, Khawar Hussain","doi":"10.1093/ced/llae266","DOIUrl":"10.1093/ced/llae266","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"1693-1694"},"PeriodicalIF":3.7,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141603391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of confocal laser scanning microscopy in histological classification and photodynamic therapy of low-risk basal cell carcinoma. 共焦激光扫描显微镜在低风险基底细胞癌组织学分类和光动力疗法中的应用评估
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2024-11-22 DOI: 10.1093/ced/llae250
Zhen Tang, Tingting Lu, Xue Chen, Jianyun Lu, Shu Ding, Aiyuan Guo, Jian Huang, Lina Tan
{"title":"Evaluation of confocal laser scanning microscopy in histological classification and photodynamic therapy of low-risk basal cell carcinoma.","authors":"Zhen Tang, Tingting Lu, Xue Chen, Jianyun Lu, Shu Ding, Aiyuan Guo, Jian Huang, Lina Tan","doi":"10.1093/ced/llae250","DOIUrl":"10.1093/ced/llae250","url":null,"abstract":"<p><strong>Background: </strong>Confocal laser scanning microscopy (CLSM) is a noninvasive technique utilized for identification and analysis of skin malignancies. Several studies have applied CLSM in monitoring the treatment of basal cell carcinoma (BCC).</p><p><strong>Objectives: </strong>To investigate the diagnostic value of CLSM in low-risk BCC and the evaluation of photodynamic therapy (PDT).</p><p><strong>Methods: </strong>We diagnosed 149 patients with BCC using CLSM and histopathological examination. Based on histopathology, we summarized the classification of low-risk BCC along with imaging features observed through CLSM. Thirty-four patients with low-risk BCC underwent PDT treatment, and we used CLSM to evaluate its efficacy.</p><p><strong>Results: </strong>Out of 149 BCCs examined by CLSM, 52 were diagnosed as the pigmented type, 87 as the nodular type and 10 as the superficial type. After histopathological examination of the 52 BCCs identified as pigmented by CLSM, 44 out of 52 were seen to be pigmented, 5 were nodular and 3 were superficial. The histopathology results were consistent with CLSM for the 87 nodular and 10 superficial BCCs. The distinguishing CLSM feature of nodular BCC was tissue fissures around the tumour, while the pigmented mass was the CLSM characteristic of the pigmented type. The simultaneous occurrence of inflammation and increased vasculature was characteristic of superficial BCC. The effective rate of PDT was 100%, and the cure rate was 68%. At the 12-month follow-up, the recurrence rate of PDT was 12%; 15% for nodular BCC, 10% for pigmented and 0% for superficial.</p><p><strong>Conclusions: </strong>The tissue classification of CLSM for low-risk BCC was consistent with histopathology. CLSM can be used to monitor the -efficacy of PDT for low-risk BCC.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"1601-1610"},"PeriodicalIF":3.7,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141475996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Skin fragility and wound management in Ehlers-Danlos syndromes: a report by the International Consortium on Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders Skin Working Group. 埃勒斯-丹洛斯综合症的皮肤脆性和伤口处理:埃勒斯-丹洛斯综合症协会皮肤工作组的报告。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2024-11-22 DOI: 10.1093/ced/llae201
Chloe Angwin, Brent J Doolan, Ingrid Hausser, Barry Labine, Mark Lavallee, Donald Mackay, F Michael Pope, Suranjith L Seneviratne, Ingrid Winship, Nigel P Burrows
{"title":"Skin fragility and wound management in Ehlers-Danlos syndromes: a report by the International Consortium on Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders Skin Working Group.","authors":"Chloe Angwin, Brent J Doolan, Ingrid Hausser, Barry Labine, Mark Lavallee, Donald Mackay, F Michael Pope, Suranjith L Seneviratne, Ingrid Winship, Nigel P Burrows","doi":"10.1093/ced/llae201","DOIUrl":"10.1093/ced/llae201","url":null,"abstract":"<p><p>The Ehlers-Danlos syndromes (EDSs) are a heterogeneous group of heritable connective tissue disorders characterized by joint hypermobility, skin hyperextensibility and generalized tissue fragility. In all types of EDS, skin wound healing is impaired to a variable degree. Additional support through wound management plans may help to improve these outcomes; however, there is a paucity of evidence regarding clinical management of skin fragility and wounds in EDS. This paper aims to review current evidence and provide recommendations for management of skin wounds in EDS types. Preventative measures to avoid skin injury are strongly recommended, including avoidance of high-impact sports and use of appropriate protection such as shin guards. Bruising is common, and some types of EDS are associated with haematoma formation, with management including compression bandages and consideration of pharmacological therapy. Skin fragility and tears should be managed with a focus on protection of remaining tissue, avoidance of wound tension and low-adherence dressings to avoid further injury. This paper provides clear recommendations to address skin management for this group of patients. It highlights the lack of good-quality published data to support treatment decisions.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"1496-1503"},"PeriodicalIF":3.7,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141064754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short-, mid- and long-term efficacy of dupilumab in moderate-to-severe atopic dermatitis: a real-world multicentre Italian study of 2576 patients. 杜匹单抗对中重度特应性皮炎的短期、中期和长期疗效:一项针对 2576 名患者的意大利多中心实际研究。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2024-11-22 DOI: 10.1093/ced/llae208
Silvia Ferrucci, Simona Tavecchio, Carlo Alberto Maronese, Anna Balato, Eugenia Veronica Di Brizzi, Michela Ortoncelli, Simone Ribero, Giampiero Girolomoni, Martina Maurelli, Anna Belloni Fortina, Francesca Caroppo, Luigi Naldi, Elena Pezzolo, Eustachio Nettis, Francesco Pugliese, Luca Stingeni, Katharina Hansel, Giovanni Rubegni, Laura Calabrese, Filomena Russo, Massimo Gola, Elisabetta Magnaterra, Franco Rongioletti, Santo Raffaele Mercuri, Giovanni Paolino, Paola Savoia, Federica Veronese, Caterina Foti, Francesca Ambrogio, Massimiliano Scalvenzi, Maddalena Napolitano, Cataldo Patruno, Stefano Dastoli, Monica Corazza, Alessandro Borghi, Pier Giacomo Calzavara-Pinton, Mariateresa Rossi, Annamaria Offidani, Giulia Radi, Laura Bonzano, Caterina Ferreli, Viviana Piras, Rosanna Satta, Federica Sucato, Piergiorgio Malagoli, Francesca Gaiani, Giuseppe Micali, Maria Letizia Musumeci, Maria Concetta Fargnoli, Maria Esposito, Teresa Grieco, Camilla Chello, Giovanni Casazza, Angelo Valerio Marzano
{"title":"Short-, mid- and long-term efficacy of dupilumab in moderate-to-severe atopic dermatitis: a real-world multicentre Italian study of 2576 patients.","authors":"Silvia Ferrucci, Simona Tavecchio, Carlo Alberto Maronese, Anna Balato, Eugenia Veronica Di Brizzi, Michela Ortoncelli, Simone Ribero, Giampiero Girolomoni, Martina Maurelli, Anna Belloni Fortina, Francesca Caroppo, Luigi Naldi, Elena Pezzolo, Eustachio Nettis, Francesco Pugliese, Luca Stingeni, Katharina Hansel, Giovanni Rubegni, Laura Calabrese, Filomena Russo, Massimo Gola, Elisabetta Magnaterra, Franco Rongioletti, Santo Raffaele Mercuri, Giovanni Paolino, Paola Savoia, Federica Veronese, Caterina Foti, Francesca Ambrogio, Massimiliano Scalvenzi, Maddalena Napolitano, Cataldo Patruno, Stefano Dastoli, Monica Corazza, Alessandro Borghi, Pier Giacomo Calzavara-Pinton, Mariateresa Rossi, Annamaria Offidani, Giulia Radi, Laura Bonzano, Caterina Ferreli, Viviana Piras, Rosanna Satta, Federica Sucato, Piergiorgio Malagoli, Francesca Gaiani, Giuseppe Micali, Maria Letizia Musumeci, Maria Concetta Fargnoli, Maria Esposito, Teresa Grieco, Camilla Chello, Giovanni Casazza, Angelo Valerio Marzano","doi":"10.1093/ced/llae208","DOIUrl":"10.1093/ced/llae208","url":null,"abstract":"<p><strong>Background: </strong>The efficacy and safety of dupilumab in atopic dermatitis (AD) have been defined in clinical trials but limited real-world evidence on long-term treatment outcomes is currently available to inform clinical decisions.</p><p><strong>Objectives: </strong>To describe the long-term effectiveness and safety of dupilumab up to 48 months in patients with moderate-to-severe AD.</p><p><strong>Methods: </strong>A multicentre, retrospective, dynamic cohort study was conducted to assess long-term effectiveness and safety of dupilumab in patients with moderate-to-severe AD in a real-world setting. Predictors of minimal disease activity (MDA) optimal treatment target criteria [defined as the simultaneous achievement of a 90% reduction in Eczema Area and Severity Index score, itch-numeric rating scale (NRS) score ≤ 1, sleep-NRS score ≤ 1 and Dermatology Life Quality Index ≤ 1] were investigated.</p><p><strong>Results: </strong>In total, 2576 patients were enrolled from June 2018 to July 2022. MDA optimal treatment target criteria were achieved by 506/2309 (21.9%), 769/1959 (39.3%), 628/1247 (50.4%), 330/596 (55.4%) and 58/106 (54.7%) of those that reached 4, 12, 24, 36 and 48 months of follow-up, respectively. Logistic regression revealed a negative effect on MDA achievement for conjunctivitis and food allergy at all timepoints. Adverse events (AEs) were mild and were observed in 373/2364 (15.8%), 166/2066 (8.0%), 83/1291 (6.4%), 27/601 (4.5%) and 5/110 (4.5%) of those that reached 4, 12, 24, 36 and 48 months of follow-up. Conjunctivitis was the most frequently reported AE during the available follow-up. AEs led to treatment discontinuation in < 1% of patients during the evaluated time periods.</p><p><strong>Conclusions: </strong>The high long-term effectiveness and safety of dupilumab were confirmed in this dynamic cohort of patients with moderate-to-severe AD, regardless of clinical phenotype and course (persisting or relapsing) at baseline. Further research will be needed to investigate the effect of T helper cell 2 comorbidities and disease duration on the response to dupilumab and other newer therapeutics for AD.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"1561-1572"},"PeriodicalIF":3.7,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141300178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medication use patterns in pregnant women with psoriasis: a nationwide study in Taiwan. 银屑病孕妇的用药模式:台湾一项全国性研究。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2024-11-22 DOI: 10.1093/ced/llae260
Chien-Hua Ou, Li-Ting Kao, Hui-Wen Yang, Yi-Lin Chiang, Yuan-Liang Wen, Sheng-Yin To, Yi-Hsien Chen
{"title":"Medication use patterns in pregnant women with psoriasis: a nationwide study in Taiwan.","authors":"Chien-Hua Ou, Li-Ting Kao, Hui-Wen Yang, Yi-Lin Chiang, Yuan-Liang Wen, Sheng-Yin To, Yi-Hsien Chen","doi":"10.1093/ced/llae260","DOIUrl":"10.1093/ced/llae260","url":null,"abstract":"<p><strong>Background: </strong>Psoriasis, an autoimmune skin condition, affects 2-4% of the global population, with significant prevalence among women of childbearing age. Pregnancy presents challenges in managing psoriasis because of hormonal changes and treatment safety concerns. Understanding treatment patterns in pregnant women is crucial, given limited real-world evidence.</p><p><strong>Objectives: </strong>To explore the utilization patterns of medications among pregnant women diagnosed with psoriasis within real-world data, utilizing data sourced from a nationwide database in Taiwan.</p><p><strong>Methods: </strong>This nationwide study utilized Taiwan's National Health Insurance (NHI) database and birth certificate application records. It included registered pregnant women diagnosed with psoriasis from 2005 to 2014. Medication usage was tracked 3 years before conception to 3 years after delivery. Medications were categorized based on Anatomical Therapeutic Chemical codes, and statistical analyses were conducted using SAS software.</p><p><strong>Results: </strong>In total, 30 267 pregnant women with psoriasis were studied. In total, 11 651 (38.5%) mothers had received ≥ 1 prescription during follow-up (exposed group) and 61.5% (18 616) had never received medication (unexposed group). Demographics and comorbidities were similar between these two groups. Topical corticosteroids were the most prescribed treatment, followed by phototherapy, with systemic drugs and biologics less common. During the study period, 11 096 women with psoriasis had used topical corticosteroids, 3376 had used nonsteroidal topical agents, 218 had used systemic agents or biologics and 519 had received treatment with phototherapy. Medication usage declined during pregnancy, reaching its lowest in the third trimester but rebounded postpartum.</p><p><strong>Conclusions: </strong>Psoriasis medications, systemic, biological or topical, were largely discontinued during pregnancy, sometimes up to 2 years before and extending postpartum. Research is needed to understand its impact on maternal and child health.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"1619-1626"},"PeriodicalIF":3.7,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141619490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of the COVID-19 pandemic on telogen effluvium: a nationwide multicentre interrupted time series study. COVID-19 大流行对毛发脱落症的影响:全国多中心间断时间序列研究。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2024-11-22 DOI: 10.1093/ced/llae331
Jee Woong Choi, Hyoung Soo Park, Sang Seok Kim, Chang-Hun Huh, Ohsang Kwon, Bark-Lynn Lew, Moon Bum Kim
{"title":"Impact of the COVID-19 pandemic on telogen effluvium: a nationwide multicentre interrupted time series study.","authors":"Jee Woong Choi, Hyoung Soo Park, Sang Seok Kim, Chang-Hun Huh, Ohsang Kwon, Bark-Lynn Lew, Moon Bum Kim","doi":"10.1093/ced/llae331","DOIUrl":"10.1093/ced/llae331","url":null,"abstract":"<p><strong>Background: </strong>There is ongoing debate regarding the association between telogen effluvium (TE) and COVID-19, as well as COVID-19 vaccines.</p><p><strong>Objectives: </strong>To investigate the impact of the COVID-19 pandemic and vaccination on the development of TE among patients visiting dermatology clinics in South Korea.</p><p><strong>Methods: </strong>Between 2017 and 2022, data regarding patients with TE and other types of hair loss were collected from 22 hospitals in South Korea. An interrupted time series analysis was conducted, dividing the time into periods before and after the COVID-19 pandemic, as well as before and after the COVID-19 vaccination.</p><p><strong>Results: </strong>There was a significant slope change in the percentage of cases of TE during the postpandemic period (slope change 0.011, 95% confidence interval 0.005-0.017, P < 0.001), but no significant changes were observed after vaccination. The percentage of patients with other types of hair loss was not associated with COVID-19 or vaccination. The retrospective nature of the study may have limited the ability to establish causation.</p><p><strong>Conclusions: </strong>This multicentre study provides insights into the epidemiology of TE, showing a significant increase in cases of TE following the COVID-19 pandemic. However, there was no association between the occurrence of TE and COVID-19 vaccines.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"1627-1632"},"PeriodicalIF":3.7,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142281275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Penile nodules and ulcer. 阴茎结节和溃疡
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2024-11-22 DOI: 10.1093/ced/llae216
Karin Savo, Pekka Taimen, Niina Hieta
{"title":"Penile nodules and ulcer.","authors":"Karin Savo, Pekka Taimen, Niina Hieta","doi":"10.1093/ced/llae216","DOIUrl":"10.1093/ced/llae216","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"1740-1743"},"PeriodicalIF":3.7,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141199553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for the development of Stevens-Johnson syndrome/toxic epidermal necrolysis following drug administration: a systematic review and meta-analysis. 用药后发生史蒂文斯-约翰逊综合征/毒性表皮坏死症的风险因素:系统回顾和荟萃分析。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2024-11-22 DOI: 10.1093/ced/llae183
Samaah Fathima, Matthew J Grainge, Hannah Wainman, Mikolaj Swiderski, Sonia Gran
{"title":"Risk factors for the development of Stevens-Johnson syndrome/toxic epidermal necrolysis following drug administration: a systematic review and meta-analysis.","authors":"Samaah Fathima, Matthew J Grainge, Hannah Wainman, Mikolaj Swiderski, Sonia Gran","doi":"10.1093/ced/llae183","DOIUrl":"10.1093/ced/llae183","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"1699-1704"},"PeriodicalIF":3.7,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140921580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trichophyton indotineae: first case in Ireland and response to topical griseofulvin. indotineae 毛癣菌:爱尔兰首例病例及对局部使用 Griseofulvin 的反应。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2024-11-22 DOI: 10.1093/ced/llae264
Emma Carroll, Marion Leahy, Maria Stanciu, Mary Laing
{"title":"Trichophyton indotineae: first case in Ireland and response to topical griseofulvin.","authors":"Emma Carroll, Marion Leahy, Maria Stanciu, Mary Laing","doi":"10.1093/ced/llae264","DOIUrl":"10.1093/ced/llae264","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"1707-1708"},"PeriodicalIF":3.7,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141615992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CorrespondenceComment on 'Gaining exposure on perceptions of sunscreen: a national survey of patients with melanoma'. 关于 "获得有关防晒感知的信息:一项针对黑色素瘤患者的全国性调查 "的评论。
IF 3.7 4区 医学
Clinical and Experimental Dermatology Pub Date : 2024-11-22 DOI: 10.1093/ced/llae270
William B Grant
{"title":"CorrespondenceComment on 'Gaining exposure on perceptions of sunscreen: a national survey of patients with melanoma'.","authors":"William B Grant","doi":"10.1093/ced/llae270","DOIUrl":"10.1093/ced/llae270","url":null,"abstract":"","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":" ","pages":"1690-1691"},"PeriodicalIF":3.7,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141626221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信